German Merck to Acquire Bio-Techne at $73 Per Share

GOOGL shares lost more than 6% in the last close, with technical indicators pointing to weakening momentum. Although the RSI is approaching oversold territory at 37, the MACD remains in negative territory and below its signal line. The price is trading below both the 20-day and 50-day moving averages. Since the headline is not directly related to Alphabet, the market impact may be limited, but the current technical outlook suggests that downward pressure could persist in the short term.

The news announces that Bio-Techne will be acquired at $73 per share. Since the current price is around $280, this offer price is very low, but acquisition news typically creates an upward movement in the stock. Although technical indicators show a neutral outlook (RSI at 49, MACD near zero), the acquisition news could generate strong buying interest in the short term. Therefore, an upward movement can be expected in the near term.